DevCurationThe Premier Voice of the Entire Tech Ecosystem
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
Hone Health Adds $28M Equity and $200M Growth Financing|Voyage Labs Raises $12M Seed for Atlas AI Travel Agent|Pulley's $64M Backs Real Estate Permitting and Site Decisions|Palo Alto Networks Plans $4.5B Applied Compute Acquisition|Compuvi Secures Consulta Bridge at $50M Post-Money Valuation|Sqwish Labs Raises $3M Pre-Seed for AI Decision Models|Speakeasy Raises $18.8M for Live-Experience Software|BrightAI Raises $97M to Expand Physical AI for Utilities|Linq Raises $90M Series B, Adds Ben Horowitz to Board|Pedestal AI Raises $4.7M Seed for Supply Chain Agents|Hone Health Adds $28M Equity and $200M Growth Financing|Voyage Labs Raises $12M Seed for Atlas AI Travel Agent|Pulley's $64M Backs Real Estate Permitting and Site Decisions|Palo Alto Networks Plans $4.5B Applied Compute Acquisition|Compuvi Secures Consulta Bridge at $50M Post-Money Valuation|Sqwish Labs Raises $3M Pre-Seed for AI Decision Models|Speakeasy Raises $18.8M for Live-Experience Software|BrightAI Raises $97M to Expand Physical AI for Utilities|Linq Raises $90M Series B, Adds Ben Horowitz to Board|Pedestal AI Raises $4.7M Seed for Supply Chain Agents
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Back to articles
November 19, 2026
•Jesse LandryJesse Landry

Hone Health Adds $28M Equity and $200M Growth Financing

The second set of lab results gives Hone Health a longer assignment than the first. A physician has a history to interpret, a treatment plan to reconsider and a patient expecting the previous conversation to count. That continuing relationship sits behind the New York telehealth company's latest financing.

Hone announced $28M in Series A extension equity and $200M in separate growth financing on November 18, 2026. MarcyPen Capital Partners led the equity investment, while General Catalyst's Customer Value Fund supplied the growth financing. Hone puts its total equity funding at $65M.

The money supports a broader physician-led longevity business spanning hormone and metabolic care, diagnostics, clinical software and research infrastructure. For healthtech operators, the transaction brings two obligations into the same expansion plan: reaching more patients and maintaining the clinical continuity that gives those patients a reason to return.

Hone's financing separates equity from the cost of growth

The $228M combined package contains different kinds of capital with different jobs. The $28M equity extension included Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital and ID Ventures. MarcyPen also disclosed that it led Hone's earlier Series A, a role the company says had not previously been made public.

Hone announced that earlier $33M Series A in January 2025. Its new release reports $65M in cumulative equity funding, which should be retained as the company's stated total rather than reconstructed from two selected announcements. The additional $200M comes from General Catalyst's Customer Value Fund; counting the whole package as newly raised equity would obscure the structure that makes the transaction interesting.

General Catalyst describes its Customer Value strategy as financing sales and marketing against the customer value that spending produces. In the firm's general model, its entitlement is capped, with the remaining customer value staying with the company after the cap is reached. Hone has not disclosed its particular repayment terms, utilization schedule or current valuation.

That approach can change what founders ask equity to fund. Patient acquisition has a commercial rhythm, while clinical tools, product development and research can require work whose payoff arrives on a different timetable. Hone's financing puts those activities under one corporate ambition while allowing different capital providers to back different parts of the effort.

The patient relationship extends beyond a diagnostic purchase

Co-founder and CEO Saad Alam describes his own experience of fatigue and hormone-health problems as part of Hone's origin. The company's proposition now reaches well beyond its early association with men's hormone care. Hone offers testing, physician consultations and treatment across hormone health, metabolic health and other longevity-related services for men and women.

The distinction matters commercially because a diagnostic result starts another set of decisions. A person may need an explanation, a treatment discussion or a change in an existing plan. Repeated testing adds context only when someone can connect the new information with what came before, including medications, symptoms and the patient's own goals.

Hone's current website describes that process as an ongoing sequence of testing, care planning and adjustment. Its disclosures also specify that Hone-affiliated medical practices are independently owned and operated by licensed physicians using the telehealth platform. The software business and the clinical practices therefore have related responsibilities, without being interchangeable entities.

Other companies are organizing care around a sustained relationship as well. DevCuration's coverage of Allara's women's health financing describes investment in connected clinical care, partnerships and research. The relevant comparison is the work required to keep care connected as a business expands, rather than a claim that the companies offer identical services or have comparable clinical results.

A wider clinical offering creates more work for the software

Hone calls its proprietary AI clinical platform Longevity OS. The company says it brings together laboratory findings, health history, symptoms, medications and longitudinal outcomes to help physicians personalize care. Its current company description keeps the decision authority explicit: AI supports physicians, while humans make treatment decisions and deliver care.

That allocation becomes more consequential as Hone broadens its services. The financing announcement identifies plans for additional clinical programs, more advanced diagnostics, AI-enabled clinical tools and clinical-trials infrastructure. Each new stream of information has to become useful inside a physician's view of the patient, rather than another isolated result demanding attention.

Hone's leadership page lists co-founders Stuart Blitz as COO, Alba Mertira as CMO, Matt Buckleman as CTO and Seth Franz as director of operations, alongside Alam. The same page also lists Manish Malik as Chief Technology Officer. Hone does not explain the relationship between those two technology titles on that page, so a reporting hierarchy should not be inferred from the labels.

The company's current hiring board includes work in clinical education, nursing navigation, data architecture and AI-focused product management. Those openings offer a concrete picture of the functions Hone is recruiting to support. They also show how much of an AI-enabled care business depends on people preparing clinicians, helping patients and maintaining usable information between encounters.

More patients make the research ambition more consequential

Hone reports more than 200,000 patients treated, 750,000 tests administered and 25M health markers processed. These company-reported figures describe cumulative activity, not independently established improvements in health outcomes. A large collection of results can support research questions, but the work of showing which interventions help which patients requires an evidence process of its own.

Clinical-trials infrastructure is therefore a meaningful destination for part of the investment. Hone says it wants to understand what kinds of care produce better outcomes. Building that capability would give the company a way to examine the relationship between its expanding services and the patient changes it seeks to support, rather than relying on diagnostic volume as a substitute for clinical evidence.

The public launch of Hone Black adds another dimension. Hone describes the concierge membership as combining extensive diagnostics with ongoing physician care after a year serving a select group of patients in stealth. The announced breadth is a description of an offering; it should not be read as proof that every therapy improves longevity or is appropriate for every patient.

Alam's team is now expanding the number of people entering that ongoing relationship and the range of questions they can bring to it. The next blood draw may arrive with a new medication, a changed symptom or a different goal. Keeping those developments connected gives Hone's physicians a continuing job as the financing begins to support a larger patient population.

DevCuration Data

Healthcare funding, last 30 days

DevCuration's funding database tracked 11 Healthcare rounds totaling $5.9B in disclosed capital over the past 30 days. Recent deals we covered:

  • KKR Completes $5.7B Acquisition of Integer Holdings$5.7B · Nov 18
  • Skribe Medical Discloses $1.65M for Cardiac WearablesPre-Seed · $1.65M · Nov 13
  • iCareManager Gains Five Elms Growth Backing for IDD CareGrowth · Nov 12
  • Triplemoon Raises $4M Seed Extension for Pediatric CareSeed Extension · $4M · Nov 12
  • EnVision Endoscopy Raises $11.5M Series A for SimpleStitchSeries A · $11.5M · Nov 12
All tracked rounds

Frequently Asked Questions

How does Hone’s equity extension differ from its growth financing?

Hone announced $28M in Series A extension equity led by MarcyPen Capital Partners and $200M in separate growth financing from General Catalyst’s Customer Value Fund. The company reports $65M in cumulative equity funding; the $200M should not be counted as equity.

Why does ongoing physician care matter to Hone’s business model?

Hone combines testing with physician consultations, treatment and repeat monitoring. The continuing relationship is intended to connect new results with earlier findings, symptoms, medications and patient goals rather than leave each test as an isolated purchase.

Who makes treatment decisions when Hone uses AI?

Hone says its Longevity OS platform supports physicians by bringing patient information together. Its current company description states that humans make treatment decisions and deliver care.

What does Hone’s reported patient scale establish?

Hone reports more than 200,000 patients treated, 750,000 tests administered and 25M health markers processed. Those company-reported activity figures do not independently establish clinical efficacy; Hone says it will invest in clinical-trials infrastructure to study outcomes.

What will the financing support beyond patient growth?

Hone identifies broader clinical programs, additional diagnostics, AI-enabled clinical tools and clinical-trials infrastructure as intended uses. It also announced the public launch of Hone Black, its concierge longevity membership.

Back to all articles
Newsletter

Where the Money Moved

The intelligence briefing of the innovation economy. Funding, M&A, debt and fund closes, read as market signal rather than deal announcements.

Subscribe to Where the Money Moved
Hone Health

Hone Health

WebsiteLinkedIn

Key Executives

  • Saad Alam
  • Co-Founder & CEO; Stuart Blitz
+5 more (coming soon)

Investors

MarcyPen Capital PartnersGeneral Catalyst's Customer Value Fund
View Career Page

Related Articles

Funding Announcement
Synctera's $24.5M Raise Backs Its Bank Infrastructure
Nov 9, 2026
Funding Announcement
Rivio Adds R$80M to Series A for Hospital Billing AI
Nov 9, 2026
Funding Announcement
Confido Health Adds $12.5M Series A Extension for CareOS
Oct 14, 2026
Funding Announcement
Mantel Adds $18M as Carbon Capture Moves Into Industry
Aug 26, 2026
Funding Announcement
Starcloud Adds $250M to Series A as Orbital Compute Meets Launch Reality
Aug 25, 2026

More from Jesse Landry

Funding Announcement
Voyage Labs Raises $12M Seed for Atlas AI Travel Agent
Nov 19, 2026
Funding Announcement
Pulley's $64M Backs Real Estate Permitting and Site Decisions
Nov 19, 2026
Funding Announcement
Palo Alto Networks Plans $4.5B Applied Compute Acquisition
Nov 19, 2026

Trending

Events
Alumni Ventures Examines Voice AI’s Business Case on Nov. 19
Nov 18, 2026
News
Serve Robotics Opens Physical AI Services to Outside Fleets
Nov 15, 2026
View all posts